Full Library
Pseudomonas aeruginosa Infections in Transplant: Epidemiology and Emerging Treatment Options
Resource type
Book Section
Authors/contributors
- Morris, Michele I. (Editor)
- Kotton, Camille Nelson (Editor)
- Wolfe, Cameron (Editor)
- Hogan, John I. (Author)
- Hill, Brandon K. (Author)
- Sifri, Costi D. (Author)
Title
Pseudomonas aeruginosa Infections in Transplant: Epidemiology and Emerging Treatment Options
Abstract
As one of the most formidable bacterial pathogens encountered in clinical practice, infections related to Pseudomonas aeruginosa (PsA) present a number of challenges to the infectious disease physician. In immunocompromised hosts in particular, PsA has the potential to manifest with unique, recurrent, and often severe clinical syndromes that warrant infectious disease consultation. A staggering array of virulence factors combined with a host of intrinsic and acquired genetic elements conferring resistance to antimicrobials can make this pathogen exceptionally difficult to manage. As the epidemiology of PsA infection in transplant patients has evolved over the past several decades, so too has this organism’s spectrum of antimicrobial resistance. The emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) isolates in recent years underscores the importance of emerging therapeutics in the treatment of complicated infections.
Book Title
Emerging Transplant Infections
Date
2021
Publisher
Springer International Publishing
Place
Cham
Pages
343-370
ISBN
978-3-030-01751-4
Accessed
10/23/21, 9:33 AM
Short Title
Pseudomonas aeruginosa Infections in Transplant
Language
en
Library Catalog
DOI.org (Crossref)
Extra
Citation
Hogan, J. I., Hill, B. K., & Sifri, C. D. (2021). Pseudomonas aeruginosa Infections in Transplant: Epidemiology and Emerging Treatment Options. In M. I. Morris, C. N. Kotton, & C. Wolfe (Eds.), Emerging Transplant Infections (pp. 343–370). Springer International Publishing. https://doi.org/10.1007/978-3-030-01751-4_20-1
TEXTBOOKS
Link to this record